[{"NetIncomeLoss_1_Q2_USD":-5563000.0,"DepreciationAndAmortization_1_Q2_USD":1099000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":16415800.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":29974811.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":2147000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":8688000.0,"InterestPaidNet_2_Q2_USD":1290000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1854000.0,"Depreciation_2_Q2_USD":814000.0,"Depreciation_1_Q2_USD":430000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":138553000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-1508000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-757000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1259000.0,"AssetsCurrent_0_Q2_USD":157409000.0,"OperatingLeaseExpense_2_Q2_USD":627000.0,"OperatingLeaseExpense_1_Q2_USD":308000.0,"LongTermDebt_0_Q2_USD":32256000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":6996465.0,"ShareBasedCompensation_2_Q2_USD":1470000.0,"Assets_0_Q2_USD":206342000.0,"CommonStockSharesIssued_0_Q2_shares":37136853.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q2_USD":3219000.0,"DepreciationAndAmortization_2_Q2_USD":2108000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2_Q2_USD":3219000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":99000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5116129.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":464000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":327000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":10066000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":18245000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1219000.0,"Liabilities_0_Q2_USD":58521000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":135464000.0,"OtherAssetsNoncurrent_0_Q2_USD":202000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-6000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-12000.0,"AccountsReceivableNetCurrent_0_Q2_USD":8158000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-52000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-118000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":2476000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":2476000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":176000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":2202000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":5815000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":6931000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":2947000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":6139000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1923000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":70542000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2174000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-176000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-6104000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-15376000.0,"IncreaseDecreaseInInventories_2_Q2_USD":2539000.0,"OtherAssetsCurrent_0_Q2_USD":7225000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":858000.0,"WarrantsAndRightsOutstanding_0_Q2_USD":192000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":2728000.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_2_Q2_USD":296000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":400000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":826000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":1590000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":136930000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_1_Q2_USD":296000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":575000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1300000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":2146000.0,"DebtInstrumentInterestRateEffectivePercentage_0_Q2_pure":0.0785,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":2147000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3078000.0,"Goodwill_0_Q2_USD":18262000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-13657000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-5569000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1216000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-16819000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":1183000.0,"CostOfRevenue_2_Q2_USD":9744000.0,"CostOfRevenue_1_Q2_USD":4937000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1179000.0,"LiabilitiesCurrent_0_Q2_USD":18161000.0,"AccountsPayableCurrent_0_Q2_USD":4898000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":135765000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":143000.0,"NetIncomeLoss_2_Q2_USD":-13645000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":6020000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":6627000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":811000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":154000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":21644000.0,"RestrictedCashNoncurrent_0_Q2_USD":301000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":1.53,"GrossProfit_1_Q2_USD":8134000.0,"GrossProfit_2_Q2_USD":15539000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":21644000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2986000.0,"LongTermDebtNoncurrent_0_Q2_USD":32256000.0,"AdditionalPaidInCapital_0_Q2_USD":214636000.0,"CommonStockSharesOutstanding_0_Q2_shares":37136853.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1688000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":118257000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2816000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":206342000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-16000.0,"TemporaryEquityAccretionOfDividends_2_Q2_USD":1435000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":27459000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":212000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4287000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"InventoryNet_0_Q2_USD":6562000.0,"OperatingIncomeLoss_1_Q2_USD":-6378000.0,"OperatingIncomeLoss_2_Q2_USD":-11779000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":13071000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":25283000.0,"DebtInstrumentFeeAmount_0_Q2_USD":1625000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":6043000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":9098000.0,"OperatingExpenses_2_Q2_USD":27318000.0,"DividendsPreferredStock_1_Q2_USD":245000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-66817000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":83000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":32500000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1854000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":996000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":1112000.0,"RedeemablePreferredStockDividends_1_Q2_USD":245000.0,"StockholdersEquity_0_Q2_USD":147821000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":288000.0,"ProfitLoss_2_Q2_USD":-13645000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.2,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.94,"OperatingExpenses_1_Q2_USD":14512000.0,"RedeemablePreferredStockDividends_2_Q2_USD":1435000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":431000.0,"Ticker":"AKYA","CIK":"1711933","name":"AKOYA BIOSCIENCES, INC.","OfficialName":"Akoya BioSciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"413727411.0","Country":"United States","Sector":"Capital Goods","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]